of glycopeptides. Glycopeptides enriched from human serum were resuspended with 10 μL solvent A (A: water with 0.1% formic acid; B: ACN with 0.1% formic acid) and then separated by nanoLC and analyzed by on-line electrospray tandem mass spectrometry. The experiments were performed on an EASY-nLC 1000 system (Thermo Fisher Scientific, Waltham, MA) connected to an Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific, San Jose, CA) equipped with an online nano-electrospray ion source. 8 μL peptide sample was loaded onto the trap column (Thermo Scientific Acclaim PepMap C18, 100μm x 2cm), with a flow of 10μL/min for 3 min and subsequently separated on the analytical column (Acclaim PepMap C18, 75μm x 25cm) with a linear gradient, from 2% B to 25% B in 105 min. The column was re-equilibrated at initial conditions for 15 min. The column flow rate was maintained at 300 nL/min and column temperature was maintained at 40 °C. The electrospray voltage of 2.0 kV versus the inlet of the mass spectrometer was used. The Orbitrap Fusion mass spectrometer was operated in the data-dependent mode to switch automatically between MS and MS/MS acquisition. Survey full-scan MS spectra (m/z 350-1500) were acquired in Orbitrap with a mass resolution of 120 000 at m/z 200. The AGC taget was set to 1 000 000, and the maximum injection time was 50ms. MS/MS acquisition was performed in Orbitrap with 3 s cycle time, the resolution was 15 000 at m/z 200. The intensity threshold was 50 000, and the maximum injection time was 100 ms. The AGC target was set to 200 000, and the isolation window was 2 m/z. Ions with charge states 2+, 3+, and 4+ were sequentially fragmented by higher energy collisional dissociation (HCD) with a normalized collision energy (NCE) of 35%, fixed first mass was set at 110. In all cases, one microscan was recorded using dynamic exclusion of 30 seconds.
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Database search. Tandem mass spectra were extracted by Proteome Discoverer software (Thermo Fisher Scientific, version 1.4.0.288). Charge state deconvolution and deisotoping were not performed. All MS/MS samples were analyzed using Mascot (Matrix Science, London, UK; version 2.3.2). The database was the Human UniProtKB/Swiss-Prot database (Release 2015-03-11, with 20199 sequences) . Raw files generated by the Orbitrap Fusion were searched directly using a 10ppm precursor mass tolerance and a 50 mmu fragment mass tolerance. The enzyme specificity with trypsin was used. Up to two missed cleavages were allowed and peptides with at least 7 amino acids were retained. Carbamidomethyl on cysteine was set as a fixed modification. Oxidation on methionine and Deamidation on asparagine were set as variable modifications. Use the percolator algorithm to control peptide level false discovery rates (FDR) lower than 1%. The Asn modification that did not occur in the N-X-S/T (X≠P) sequon was eliminated to ensure the false positive rate below 1% for the identified glycosylation sites. 
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